A major new inhaler announcement has been made today, Tuesday, July 21, for asthma patients. In the UK, more than seven ...

A new market forecast indicates robust growth driven by the integration of digital health technologies aimed at improving medication adherence and enabling remote patient monitoring for chronic ...

Opportunities include sustainable MDI technologies, advanced manufacturing and testing equipment, regulatory and quality services, intellectual property support, fault investigation, and workforce ...

The MHRA has approved the world's first lower-carbon pressurised asthma inhalers, marking a significant step towards reducing ...

PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

Two new pressurised metered dose inhalers (pMDIs) with lower carbon emissions have been approved by the UK’s drug regulator ...

The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer. SAN ANTONIO — In the United States, two-thirds ...

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...

A total of 425 patients were included in both the modified intention-to-treat and safety analyses. ATLANTA, GA—Findings of a Phase 3 study (NCT02513160) presented at the 2017 AAAAI Annual Meeting ...

A recent study published in Canadian Journal of Health Technologies examined the effectiveness of using metered-dose inhalers (MDIs) for medical cannabis and the evidence based guidelines for MDI use.

ATLANTA, Georgia — Patients with chronic obstructive pulmonary disease (COPD) experience few adverse events and discontinuations when treated with an ipratropium plus albuterol inhalation spray (CVT-R ...